What is the appropriate management for a patient presenting with opsoclonus and a Glasgow Coma Scale of 3?

Management of Opsoclonus with GCS 3

A patient presenting with opsoclonus and GCS 3 requires immediate ICU admission with aggressive resuscitation, airway protection through intubation, and urgent workup to identify the underlying etiology (particularly neuroblastoma in children or paraneoplastic causes in adults), followed by high-dose immunosuppression once stabilized.

Immediate Stabilization (First Priority)

This is a medical emergency requiring immediate life-saving interventions:

• Secure the airway immediately - GCS 3 indicates deep coma with inability to protect airway; proceed with rapid sequence intubation 1
• ICU-level monitoring with continuous vital signs, neurological assessments, and arterial line for blood pressure monitoring 1
• Maintain MAP >60-65 mmHg to ensure adequate cerebral perfusion 1
• Target normoxia (PaO2 10-13 kPa, SaO2 94-98%) and normocapnia (PaCO2 4.5-6 kPa) with mechanical ventilation using tidal volumes of 6-8 mL/kg 1
• Correct hypoglycemia immediately if present - check glucose stat 2
• Seizure management if present: Use levetiracetam or sodium valproate as first-line agents 1

Critical Caveat on Prognosis

While GCS 3 traditionally carries grave prognosis, do NOT withdraw care prematurely. Studies show 50.8% survival and 13.2% good functional outcome at 6 months in trauma patients with GCS 3 3. The key is pupillary reactivity: bilateral reactive pupils have 76.5% survival versus 20.3% with bilateral fixed dilated pupils 3, 4. Aggressive initial treatment is warranted for 24-72 hours to allow physiological stabilization and reassessment 5.

Urgent Diagnostic Workup (Within Hours)

Neuroimaging

• MRI brain with and without contrast (preferred) or CT if MRI unavailable 6
• Look for: mass lesions, herniation, midline shift, paraneoplastic changes

Neurological Consultation

• Immediate neurology consultation required 6
• Consider EEG if unexplained altered mental status or concern for seizures 7

Paraneoplastic Workup (Essential for Opsoclonus)

Based on the 2022 international consensus on opsoclonus-myoclonus-ataxia syndrome 8:

• Neuroblastoma screening (especially in children):

  • Urine catecholamines (VMA, HVA)
  • CT chest/abdomen/pelvis
  • MIBG scan if available

• Paraneoplastic antibody panel 6:

  • ANNA-1 (anti-Hu)
  • Anti-Ri antibodies
  • Other paraneoplastic markers as indicated

Lumbar Puncture

• CSF analysis for: cell count, protein, glucose, cytology, cultures 6
• Note: CSF may show elevated protein and lymphocytic pleocytosis in immune-mediated conditions

Additional Labs

• CBC, CMP, inflammatory markers (ESR, CRP)
• Coagulation studies
• Infectious workup if indicated

Immunosuppressive Treatment (After Stabilization)

Once the patient is hemodynamically stable and workup initiated:

First-Line Therapy

High-dose corticosteroids 6, 8:

• Methylprednisolone 1 gram IV daily for 3-5 days (pulse dosing) 6
• Then transition to oral prednisone with slow taper over 4-6 weeks based on clinical response

Second-Line Therapy (If Inadequate Response)

IVIG or Plasmapheresis 6:

• IVIG 2 g/kg IV over 5 days (0.4 g/kg/day) OR
• Plasmapheresis for 3-5 days

Third-Line Therapy (Refractory Cases)

• Rituximab if refractory to steroids and IVIG/plasmapheresis 6

Monitoring During ICU Stay

• Serial neurological examinations at least twice daily - monitor GCS, pupillary reactions 5
• Reassess every 24-72 hours for improvement or deterioration 5
• Frequent neuro checks and pulmonary function monitoring 6
• Monitor for autonomic dysfunction 6
• Daily review by neurology team 6

Treatment Limitations Discussion

Given the severity (GCS 3), establish treatment limitations early 5:

• Consider DNACPR order
• Discuss goals of care with family
• Allow 24-72 hours of aggressive treatment before prognostication 5
• If bilateral fixed dilated pupils present, prognosis is significantly worse but not absolutely futile - 20.3% still survive 3

Specific Considerations for Opsoclonus

Opsoclonus-myoclonus-ataxia syndrome is immune-mediated and potentially paraneoplastic 8. The presence of opsoclonus with GCS 3 suggests either:

1. Severe encephalopathy from underlying malignancy
2. Fulminant immune-mediated encephalitis
3. Concurrent structural brain injury

The opsoclonus itself is treatable with immunosuppression, but the GCS 3 indicates life-threatening brain dysfunction requiring immediate stabilization before definitive immunotherapy can be effective 8.

Key Pitfalls to Avoid

1. Do not assume futility based on GCS 3 alone - aggressive treatment for 24-72 hours is warranted 5, 3
2. Do not delay intubation - GCS 3 cannot protect airway
3. Do not miss neuroblastoma in children with opsoclonus - this is the most common cause
4. Do not use prophylactic anticonvulsants unless seizures occur 1, 9
5. Do not hyperventilate unless acute herniation - target normocapnia 1, 2